ALNY Insider Trading

Insider Ownership Percentage: 0.86%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $96,139,471.95

Alnylam Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Alnylam Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alnylam Pharmaceuticals Share Price & Price History

Current Price: $295.05
Price Change: Price Decrease of -0.86 (-0.29%)
As of 05/8/2026 04:00 PM ET

This chart shows the closing price history over time for ALNY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Alnylam Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/6/2026Melissa McLaughlinInsiderSell2,286$330.42$755,340.129,443View SEC Filing Icon  
4/2/2026Melissa McLaughlinInsiderSell1,624$319.59$519,014.1611,729View SEC Filing Icon  
3/3/2026Kevin Joseph FitzgeraldEVPSell1,652$319.73$528,193.9621,860View SEC Filing Icon  
3/3/2026Pushkal GargEVPSell1,775$319.74$567,538.5023,406View SEC Filing Icon  
3/2/2026Jeffrey V. PoultonEVPSell2,206$327.65$722,795.9064,273View SEC Filing Icon  
3/2/2026Kevin Joseph FitzgeraldEVPSell1,598$327.65$523,584.7023,512View SEC Filing Icon  
3/2/2026Pushkal GargEVPSell1,717$327.66$562,592.2225,181View SEC Filing Icon  
3/2/2026Tolga TangulerEVPSell1,598$327.65$523,584.7036,606View SEC Filing Icon  
3/2/2026Yvonne GreenstreetCEOSell6,799$327.65$2,227,692.3598,628View SEC Filing Icon  
2/17/2026Kevin Joseph FitzgeraldEVPSell2,041$331.96$677,530.3621,264View SEC Filing Icon  
2/13/2026Jeffrey V. PoultonEVPSell2,242$310.08$695,199.3659,802View SEC Filing Icon  
2/13/2026Kevin Joseph FitzgeraldEVPSell1,959$310.08$607,446.7223,305View SEC Filing Icon  
2/13/2026Pushkal GargEVPSell2,242$310.08$695,199.3624,848View SEC Filing Icon  
2/13/2026Tolga TangulerEVPSell1,959$310.08$607,446.7231,769View SEC Filing Icon  
2/13/2026Yvonne GreenstreetCEOSell6,958$310.08$2,157,536.6485,662View SEC Filing Icon  
1/13/2026Kevin Joseph FitzgeraldEVPSell2,290$370.33$848,055.7021,264View SEC Filing Icon  
1/12/2026Jeffrey V. PoultonEVPSell2,780$362.87$1,008,778.6057,465View SEC Filing Icon  
1/12/2026Kevin Joseph FitzgeraldEVPSell1,510$362.87$547,933.7023,554View SEC Filing Icon  
1/12/2026Pushkal GargEVPSell1,510$362.87$547,933.7022,511View SEC Filing Icon  
1/12/2026Tolga TangulerEVPSell1,510$362.87$547,933.7029,728View SEC Filing Icon  
1/12/2026Yvonne GreenstreetCEOSell9,577$362.86$3,475,110.2278,411View SEC Filing Icon  
11/17/2025Kevin Joseph FitzgeraldEVPSell12,128$452.18$5,484,039.0421,264View SEC Filing Icon  
11/13/2025Yvonne GreenstreetCEOSell10,000$451.27$4,512,700.0065,409View SEC Filing Icon  
11/12/2025Yvonne GreenstreetCEOSell15,650$453.69$7,100,248.5065,409View SEC Filing Icon  
10/3/2025Pushkal GargEVPSell3,022$451.48$1,364,372.5620,221View SEC Filing Icon  
10/2/2025Jeffrey V. PoultonEVPSell3,821$452.05$1,727,283.0554,052View SEC Filing Icon  
10/2/2025Kevin Joseph FitzgeraldEVPSell2,441$452.05$1,103,454.0525,231View SEC Filing Icon  
10/2/2025Pushkal GargEVPSell2,937$452.05$1,327,670.8523,243View SEC Filing Icon  
10/2/2025Tolga TangulerEVPSell1,405$452.05$635,130.2527,438View SEC Filing Icon  
10/2/2025Yvonne GreenstreetCEOSell8,924$452.05$4,034,094.2065,409View SEC Filing Icon  
9/9/2025Colleen F. ReitanDirectorSell18,000$467.60$8,416,800.00775View SEC Filing Icon  
8/19/2025Pushkal GargEVPSell1,455$458.41$666,986.5520,221View SEC Filing Icon  
8/18/2025Jeffrey V. PoultonEVPSell2,274$453.27$1,030,735.9850,121View SEC Filing Icon  
8/18/2025Kevin Joseph FitzgeraldEVPSell1,396$453.27$632,764.9222,719View SEC Filing Icon  
8/18/2025Michael W. BonneyDirectorSell11,250$450.00$5,062,500.0016,804View SEC Filing Icon  
8/18/2025Pushkal GargEVPSell1,396$453.27$632,764.9221,676View SEC Filing Icon  
8/18/2025Tolga TangulerEVPSell1,396$453.27$632,764.9229,466View SEC Filing Icon  
8/18/2025Yvonne GreenstreetCEOSell6,979$453.27$3,163,371.3356,221View SEC Filing Icon  
8/14/2025Dennis A. AusielloDirectorSell31,448$436.58$13,729,567.84911View SEC Filing Icon  
6/2/2025Yvonne GreenstreetCEOSell19,297$306.00$5,904,882.0048,948View SEC Filing Icon  
5/30/2025Yvonne GreenstreetCEOSell31,640$304.39$9,630,899.6048,948View SEC Filing Icon  
2/18/2025Kevin Joseph FitzgeraldEVPSell1,440$251.56$362,246.4012,881View SEC Filing Icon  
2/18/2025Pushkal GargCMOSell1,548$251.67$389,585.1611,989View SEC Filing Icon  
2/14/2025Jeffrey V. PoultonCFOSell967$255.17$246,749.3932,786View SEC Filing Icon  
2/14/2025Kevin Joseph FitzgeraldEVPSell663$255.21$169,204.2314,321View SEC Filing Icon  
2/14/2025Pushkal GargCMOSell1,561$255.17$398,320.3713,537View SEC Filing Icon  
2/14/2025Yvonne GreenstreetCEOSell1,213$255.17$309,521.2181,526View SEC Filing Icon  
1/27/2025Pushkal GargCMOSell52,592$285.00$14,988,720.0011,989View SEC Filing Icon  
1/23/2025Phillip A. SharpDirectorSell11,250$275.00$3,093,750.00View SEC Filing Icon  
12/12/2024Pushkal GargCMOSell1,752$251.00$439,752.0015,705View SEC Filing Icon  
11/26/2024Pushkal GargCMOSell1,682$250.98$422,148.3617,457View SEC Filing Icon  
11/26/2024Tolga TangulerEVPSell1,469$250.98$368,689.6213,191View SEC Filing Icon  
11/26/2024Yvonne GreenstreetCEOSell5,219$250.98$1,309,864.6278,880View SEC Filing Icon  
8/20/2024Yvonne GreenstreetCEOSell15,000$280.00$4,200,000.0073,441View SEC Filing Icon  
8/6/2024Dennis A. AusielloDirectorSell20,250$262.00$5,305,500.00136View SEC Filing Icon  
8/1/2024Yvonne GreenstreetCEOSell15,148$270.00$4,089,960.0073,441View SEC Filing Icon  
7/11/2024Yvonne GreenstreetCEOSell7,093$261.00$1,851,273.0073,441View SEC Filing Icon  
6/25/2024Jeffrey V. PoultonCFOSell1,605$231.00$370,755.0028,892View SEC Filing Icon  
6/25/2024Kevin Joseph FitzgeraldEVPSell1,198$230.99$276,726.0214,181View SEC Filing Icon  
6/25/2024Pushkal GargCMOSell2,103$230.99$485,771.9715,609View SEC Filing Icon  
6/25/2024Yvonne GreenstreetCEOSell8,301$230.99$1,917,447.9980,534View SEC Filing Icon  
6/24/2024David E. I. PyottDirectorSell32,450$220.69$7,161,390.50136View SEC Filing Icon  
5/29/2024Amy W. SchulmanDirectorSell21,700$148.60$3,224,620.008,436View SEC Filing Icon  
12/27/2023Michael W. BonneyDirectorSell30,000$195.00$5,850,000.0016,029View SEC Filing Icon  
8/7/2023Pushkal GargCMOSell4,166$183.89$766,085.744,345View SEC Filing Icon  
8/4/2023Jeffrey V. PoultonCFOSell3,460$185.85$643,041.0015,873View SEC Filing Icon  
8/4/2023Pushkal GargCMOSell3,461$185.85$643,226.858,511View SEC Filing Icon  
8/4/2023Yvonne GreenstreetCEOSell4,057$185.85$753,993.4535,216View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.97% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALNY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alnylam Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/8/2026PNC Financial Services Group Inc.12,322$4.08M0.0%-2.8%0.009%Search for SEC Filing on Google Icon
5/8/2026Andra AP fonden86,697$28.69M0.4%+78.6%0.065%Search for SEC Filing on Google Icon
5/7/2026Dimensional Fund Advisors LP384,205$127.07M0.0%+27.3%0.288%Search for SEC Filing on Google Icon
5/7/2026Parallel Advisors LLC891$0.30M0.0%+7.9%0.001%Search for SEC Filing on Google Icon
5/7/2026AlphaCentric Advisors LLC1,370$0.45M0.5%+5.8%0.001%Search for SEC Filing on Google Icon
5/7/2026KBC Group NV20,524$6.79M0.0%-94.1%0.015%Search for SEC Filing on Google Icon
5/7/2026S&CO Inc.7,400$2.45M0.2%-9.8%0.006%Search for SEC Filing on Google Icon
5/7/2026SEB Asset Management AB30,153$9.98M0.0%N/A0.023%Search for SEC Filing on Google Icon
5/7/2026Swiss National Bank387,720$128.29M0.1%+7.9%0.290%Search for SEC Filing on Google Icon
5/7/2026AIA Group Ltd7,742$2.56M0.0%-61.6%0.006%Search for SEC Filing on Google Icon
5/7/2026Mediolanum International Funds Ltd45,119$14.26M0.2%+6.2%0.034%Search for SEC Filing on Google Icon
5/6/2026California Public Employees Retirement System227,997$75.44M0.0%-3.8%0.171%Search for SEC Filing on Google Icon
5/6/2026Assetmark Inc.14,207$4.70M0.0%-11.4%0.011%Search for SEC Filing on Google Icon
5/6/2026Bessemer Group Inc.122$40K0.0%-46.3%0.000%Search for SEC Filing on Google Icon
5/6/2026Allspring Global Investments Holdings LLC281,793$92.63M0.2%+1.1%0.211%Search for SEC Filing on Google Icon
5/6/2026Independent Financial Group LLC630$0.21M0.0%N/A0.000%Search for SEC Filing on Google Icon
5/6/2026Aware Super Pty Ltd as trustee of Aware Super5,473$1.81M0.0%N/A0.004%Search for SEC Filing on Google Icon
5/5/2026Wealthfront Advisers LLC11,587$3.83M0.0%-36.5%0.009%Search for SEC Filing on Google Icon
5/5/2026Marks Group Wealth Management Inc1,650$0.55M0.1%N/A0.001%Search for SEC Filing on Google Icon
5/5/2026Illinois Municipal Retirement Fund24,295$8.04M0.1%-5.7%0.018%Search for SEC Filing on Google Icon
5/5/2026MASTERINVEST Kapitalanlage GmbH1,179$0.39M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/5/2026Sanctuary Advisors LLC5,839$1.93M0.0%-10.4%0.004%Search for SEC Filing on Google Icon
5/4/2026Principal Financial Group Inc.5,649$1.87M0.0%+61.5%0.004%Search for SEC Filing on Google Icon
5/4/2026J. Safra Sarasin Holding AG3,230$1.07M0.0%-64.7%0.002%Search for SEC Filing on Google Icon
5/4/2026Teachers Retirement System of The State of Kentucky30,696$10.16M0.1%-2.9%0.023%Search for SEC Filing on Google Icon
5/2/2026Anchor Investment Management LLC2,819$0.93M0.1%+4.6%0.002%Search for SEC Filing on Google Icon
5/1/2026Fifth Third Bancorp9,568$3.17M0.0%+7,433.9%0.007%Search for SEC Filing on Google Icon
5/1/2026Sequoia Financial Advisors LLC4,560$1.51M0.0%+8.3%0.003%Search for SEC Filing on Google Icon
4/30/2026First Horizon Corp113$37K0.0%-30.7%0.000%Search for SEC Filing on Google Icon
4/30/2026Kestra Advisory Services LLC1,184$0.39M0.0%-36.0%0.001%Search for SEC Filing on Google Icon
4/30/2026Sumitomo Mitsui Trust Group Inc.314,417$104.03M0.1%-4.1%0.236%Search for SEC Filing on Google Icon
4/30/2026Resona Asset Management Co. Ltd.39,832$13.09M0.1%+1.5%0.030%Search for SEC Filing on Google Icon
4/30/2026Capstone Capital Management Ltd1,767$0.59M0.6%-23.2%0.001%Search for SEC Filing on Google Icon
4/29/2026Burney Co.3,411$1.13M0.0%-25.6%0.003%Search for SEC Filing on Google Icon
4/29/2026Swedbank AB62,215$20.59M0.0%+0.4%0.047%Search for SEC Filing on Google Icon
4/28/2026Whittier Trust Co. of Nevada Inc.219$72K0.0%+167.1%0.000%Search for SEC Filing on Google Icon
4/28/2026Ascentis Independent Advisors194$64K0.0%N/A0.000%Search for SEC Filing on Google Icon
4/28/2026Kepler Cheuvreux Suisse SA1,713$0.57M0.0%N/A0.001%Search for SEC Filing on Google Icon
4/28/2026QRG Capital Management Inc.2,277$0.75M0.0%-3.6%0.002%Search for SEC Filing on Google Icon
4/27/2026HB Wealth Management LLC1,995$0.66M0.0%+17.3%0.001%Search for SEC Filing on Google Icon
4/27/2026Sierra Summit Advisors LLC30,298$10.03M1.5%N/A0.023%Search for SEC Filing on Google Icon
4/27/2026Y Intercept Hong Kong Ltd11,361$3.76M0.1%N/A0.009%Search for SEC Filing on Google Icon
4/27/2026Bronte Capital Management Pty Ltd.37,245$12.32M1.3%-4.2%0.028%Search for SEC Filing on Google Icon
4/27/2026Leonteq Securities AG248$82K0.0%+136.2%0.000%Search for SEC Filing on Google Icon
4/27/2026Fjarde AP Fonden Fourth Swedish National Pension Fund48,705$16.12M0.1%+61.2%0.037%Search for SEC Filing on Google Icon
4/27/2026Elevation Point Wealth Partners LLC1,263$0.42M0.0%N/A0.001%Search for SEC Filing on Google Icon
4/27/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.37,025$12.25M0.4%+80.8%0.028%Search for SEC Filing on Google Icon
4/25/2026Strs Ohio35,532$11.76M0.0%+26.7%0.027%Search for SEC Filing on Google Icon
4/25/2026Keybank National Association OH3,239$1.07M0.0%-2.9%0.002%Search for SEC Filing on Google Icon
4/24/2026Fulton Bank N.A.1,549$0.51M0.0%+8.3%0.001%Search for SEC Filing on Google Icon
4/24/2026USS Investment Management Ltd26,848$8.88M0.0%+2.4%0.020%Search for SEC Filing on Google Icon
4/24/2026IFM Investors Pty Ltd27,266$9.02M0.1%+3.9%0.020%Search for SEC Filing on Google Icon
4/24/2026iA Global Asset Management Inc.15,922$5.27M0.1%-10.4%0.012%Search for SEC Filing on Google Icon
4/23/2026Lansforsakringar Fondforvaltning AB publ 41,890$13.86M0.1%-1.1%0.031%Search for SEC Filing on Google Icon
4/23/2026Apollon Wealth Management LLC767$0.25M0.0%N/A0.001%Search for SEC Filing on Google Icon
4/22/2026Janney Montgomery Scott LLC9,339$3.09M0.0%+43.6%0.007%Search for SEC Filing on Google Icon
4/22/2026Pictet Asset Management Holding SA237,920$77.49M0.1%-24.7%0.178%Search for SEC Filing on Google Icon
4/22/2026Sterling Capital Management LLC5,182$1.72M0.0%+45.7%0.004%Search for SEC Filing on Google Icon
4/21/2026Cannon Global Investment Management LLC2,400$0.79M1.6%N/A0.002%Search for SEC Filing on Google Icon
4/21/2026Draper Asset Management LLC3,773$1.25M0.7%+55.8%0.003%Search for SEC Filing on Google Icon
4/21/2026Aaron Wealth Advisors LLC729$0.24M0.0%-21.8%0.001%Search for SEC Filing on Google Icon
4/21/2026Louisiana State Employees Retirement System8,700$2.88M0.1%N/A0.007%Search for SEC Filing on Google Icon
4/20/2026OP Asset Management Ltd23,477$7.77M0.1%N/A0.018%Search for SEC Filing on Google Icon
4/20/2026Banque Cantonale Vaudoise5,978$1.98M0.1%-45.8%0.004%Search for SEC Filing on Google Icon
4/20/2026Assenagon Asset Management S.A.128,896$42.65M0.1%+403.7%0.097%Search for SEC Filing on Google Icon
4/18/2026Faithward Advisors LLC3,961$1.31M0.2%+5.0%0.003%Search for SEC Filing on Google Icon
4/17/2026Krilogy Financial LLC1,173$0.38M0.0%-26.1%0.001%Search for SEC Filing on Google Icon
4/16/2026SG Americas Securities LLC55,060$18.22M0.0%-39.4%0.041%Search for SEC Filing on Google Icon
4/16/2026Evolve Private Wealth LLC1,100$0.36M0.0%-38.3%0.001%Search for SEC Filing on Google Icon
4/16/2026Founders Financial Securities LLC1,361$0.44M0.0%N/A0.001%Search for SEC Filing on Google Icon
4/16/2026BI Asset Management Fondsmaeglerselskab A S5,697$1.89M0.0%-61.7%0.004%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.8,124$3.23M0.0%+85.5%0.006%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC23,763$9.45M0.0%-39.7%0.018%Search for SEC Filing on Google Icon
3/6/2026Hsbc Holdings PLC89,517$35.68M0.0%+22.6%0.067%Search for SEC Filing on Google Icon
3/4/2026SHP Wealth Management109$43K0.0%N/A0.000%Search for SEC Filing on Google Icon
3/2/2026Reflection Asset Management159$63K0.0%N/A0.000%Search for SEC Filing on Google Icon
3/2/2026Wick Capital Partners LLC769$0.31M0.1%N/A0.001%Search for SEC Filing on Google Icon
2/27/2026Groupama Asset Managment35,878$14.27M0.2%-99.1%0.027%Search for SEC Filing on Google Icon
2/26/2026Alpine Global Management LLC2,062$0.82M0.1%N/A0.002%Search for SEC Filing on Google Icon
2/26/2026Anchor Investment Management LLC2,695$1.07M0.1%+19.8%0.002%Search for SEC Filing on Google Icon
2/25/2026MidFirst Bank541$0.22M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/24/2026Pacer Advisors Inc.9,588$3.81M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/23/2026Virtu Financial LLC2,941$1.17M0.0%-74.8%0.002%Search for SEC Filing on Google Icon
2/23/2026MV Capital Management Inc.63$25K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/20/2026Kovitz Investment Group Partners LLC1,955$0.78M0.0%-25.0%0.001%Search for SEC Filing on Google Icon
2/19/2026T. Rowe Price Investment Management Inc.1,753,640$697.34M0.4%-19.3%1.322%Search for SEC Filing on Google Icon
2/19/2026Compound Planning Inc.907$0.36M0.0%-3.7%0.001%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC23,645$9.40M0.0%-40.0%0.018%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV11,786$4.69M0.0%+2.6%0.009%Search for SEC Filing on Google Icon
2/18/2026Raymond James Financial Inc.388,705$154.43M0.0%+3.0%0.294%Search for SEC Filing on Google Icon
2/18/2026Vident Advisory LLC5,155$2.05M0.0%-1.6%0.004%Search for SEC Filing on Google Icon
2/18/2026Beacon Pointe Advisors LLC790$0.31M0.0%-17.2%0.001%Search for SEC Filing on Google Icon
2/18/2026EP Wealth Advisors LLC671$0.27M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp12,395$4.91M0.0%+26.8%0.009%Search for SEC Filing on Google Icon
2/18/2026Coastal Bridge Advisors LLC1,048$0.42M0.0%-4.5%0.001%Search for SEC Filing on Google Icon
2/18/2026Empowered Funds LLC19,431$7.73M0.1%+353.5%0.015%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd1,856$0.74M0.0%+122.5%0.001%Search for SEC Filing on Google Icon
2/18/2026Zacks Investment Management12,008$4.78M0.0%+0.9%0.009%Search for SEC Filing on Google Icon
2/18/2026Zurich Insurance Group Ltd FI30,322$12.06M0.1%+1.1%0.023%Search for SEC Filing on Google Icon
2/18/2026Utah Retirement Systems20,725$8.24M0.1%+0.6%0.016%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Read More on Alnylam Pharmaceuticals

Today's Range

Now: $295.05
Low: $293.06
High: $300.17

50 Day Range

MA: $318.15
Low: $295.91
High: $339.41

52 Week Range

Now: $295.05
Low: $250.35
High: $495.55

Volume

926,759 shs

Average Volume

1,133,140 shs

Market Capitalization

$39.39 billion

P/E Ratio

80.61

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top insider investors include:
  1. Phillip A Sharp (Director)
  2. Philip A Sharp (Director)
  3. John Maraganore (CEO)
  4. Barry E Greene (President)
  5. Philip A Sharp (Director)
  6. Yvonne Greenstreet (CEO)
  7. Jeffrey V Poulton (EVP)
  8. Akshay Vaishnaw (Insider)
  9. Akshay Vaishnaw (EVP)
  10. Akshay Vaishnaw (SVP)
Learn More about top insider investors at Alnylam Pharmaceuticals.

Who are the major institutional investors of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top institutional shareholders include:
  1. Swiss National Bank — 0.29%
  2. Dimensional Fund Advisors LP — 0.29%
  3. Sumitomo Mitsui Trust Group Inc. — 0.24%
  4. Allspring Global Investments Holdings LLC — 0.21%
  5. Pictet Asset Management Holding SA — 0.18%
  6. California Public Employees Retirement System — 0.17%
Learn More about top institutional investors of Alnylam Pharmaceuticals stock.

Which major investors are selling Alnylam Pharmaceuticals stock?

In the last quarter, ALNY stock was sold by these institutional investors:
  1. KBC Group NV
  2. Pictet Asset Management Holding SA
  3. SG Americas Securities LLC
  4. Sumitomo Mitsui Trust Group Inc.
  5. AIA Group Ltd
  6. BI Asset Management Fondsmaeglerselskab A S
  7. California Public Employees Retirement System
  8. Wealthfront Advisers LLC
During the last year, company insiders that have sold Alnylam Pharmaceuticals company stock include:
  1. Yvonne Greenstreet (CEO)
  2. Jeffrey V Poulton (EVP)
  3. Tolga Tanguler (EVP)
  4. Kevin Joseph Fitzgerald (EVP)
  5. Pushkal Garg (EVP)
  6. Michael W Bonney (Director)
  7. Melissa Mclaughlin (Insider)
  8. Dennis A Ausiello (Director)
  9. Colleen F Reitan (Director)
Learn More investors selling Alnylam Pharmaceuticals stock.

Which major investors are buying Alnylam Pharmaceuticals stock?

In the previous quarter, ALNY stock was acquired by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Dimensional Fund Advisors LP
  3. Andra AP fonden
  4. Sierra Summit Advisors LLC
  5. SEB Asset Management AB
  6. Swiss National Bank
  7. OP Asset Management Ltd
  8. Fjarde AP Fonden Fourth Swedish National Pension Fund